Skip to content

Endothelial Dysfunction and Coronary Artery Spasm

Digital Tonometry for Measurement of Peripheral Artery Reactive Hyperemia as Non-invasive Test for Diagnosis of Coronary Artery Spasm

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00619294
Enrollment
158
Registered
2008-02-20
Start date
2006-08-31
Completion date
2009-05-31
Last updated
2013-09-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary Vasospasm

Keywords

Coronary Vasospasm, Endothelium, Vascular, Vasodilation, Hyperemia

Brief summary

Non-obstructive coronary artery disease (NOCAD) frequently accounts for myocardial ischemia in women. Endothelial dysfunction is a pathogenic factor in coronary spastic angina (CSA). CSA is an important cause of NOCAD diagnosed invasively by coronary angiography (CAG). Digital reactive hyperemia peripheral arterial tonometry (RH-PAT) provides noninvasive evaluation of endothelial dysfunction. The investigators hypothesized that the fingertip RH-PAT could predict the presence of CSA in women.

Detailed description

Outline of methods: RH-PAT was measured in women with chest pain prior to CAG. Coronary spasm was diagnosed by intra-coronary acetylcholine (ACh) provocation test. Using Flow-Wire, we assessed coronary endothelial function by coronary blood flow increase in response to ACh (ACh-CBF) and coronary flow reserve was assessed by adenosine (Ad-CFR).

Interventions

None listed

Sponsors

Kumamoto University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
40 Years to 90 Years
Healthy volunteers
No

Inclusion criteria

* Stable post-menopausal women complaining angina-like chest pain

Exclusion criteria

* Severe valvular disease * Hypertrophic cardiomyopathy * Severe peripheral artery disease * Uncontrolled hypertension * Severe collagen diseases * Acute coronary syndrome

Design outcomes

Primary

MeasureTime frame
Ischemic heart disease diagnosed by cardiac catheterizationFrom Aug 2006 to May 2009

Countries

Japan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 31, 2026